Does Medicare Part D cover Ozempic for weight loss?

No. Medicare Part D covers Ozempic only when prescribed for type 2 diabetes. For weight loss, the Medicare GLP-1 Bridge covers Wegovy, Zepbound, and Foundayo at a flat $50 per month starting July 2026.

Can I ask my doctor to switch from Ozempic to Wegovy for Medicare coverage?

Yes. If you meet the BMI and health requirements, your doctor can prescribe Wegovy instead. Wegovy contains the same active ingredient as Ozempic (semaglutide) but at a higher dose with FDA approval for weight management, which qualifies for the Bridge.

Does Medicare cover Ozempic for type 2 diabetes?

Yes. Ozempic is covered under Medicare Part D when prescribed for type 2 diabetes. The $50 GLP-1 Bridge applies only to weight-management drugs — Ozempic for diabetes uses the standard Part D benefit with normal cost-sharing.

What is the difference between Ozempic and Wegovy on Medicare?

Both contain semaglutide, but at different doses with different FDA approvals. Medicare covers Ozempic for diabetes through Part D. Wegovy — approved for weight loss — is covered under the Bridge at $50 per month for eligible seniors.

Does Medicare Cover Ozempic in 2026?

The Short Answer

Ozempic is covered by Medicare — but only for type 2 diabetes. If you are asking about Ozempic for weight loss, Medicare does not cover it in that role. The drug covered for weight loss under the new 2026 GLP-1 Bridge is Wegovy, not Ozempic — even though both contain the same active ingredient, semaglutide.

This single distinction trips up thousands of seniors every year. They ask their doctor for Ozempic because it is the name they have heard, but the prescription that unlocks Medicare coverage is Wegovy.

What Is Ozempic?

Ozempic is a brand-name weekly injection made by Novo Nordisk. Its active ingredient is semaglutide, a GLP-1 receptor agonist that lowers blood sugar by stimulating insulin release and slowing digestion. The FDA approved Ozempic in 2017 specifically for the treatment of type 2 diabetes in adults.

As a diabetes drug with an approved indication, Ozempic falls under Medicare Part D like other prescription medications. Most Part D plans carry it on their formulary, though your specific tier and copay vary by plan.

Why Medicare Covers Ozempic for Diabetes

Medicare Part D has covered Ozempic for type 2 diabetes since shortly after its approval. When a drug has an FDA-approved indication that falls within Part D's covered categories, plans can include it on their formulary. Diabetes treatment is a covered category. So Ozempic for diabetes = covered.

Your out-of-pocket cost depends on your plan's formulary tier and annual deductible, but in general you pay the standard Part D cost-sharing structure — not $1,000+ per month out of pocket.

Why Medicare Does Not Cover Ozempic for Weight Loss

Here is the critical distinction that confuses many patients and even some providers.

Federal law — specifically the Social Security Act — historically excluded drugs used "for anorexia, weight loss, or weight gain" from Part D coverage. This was written decades before GLP-1 medications existed, but the language stuck. Ozempic is FDA-approved for diabetes, not for weight management. Medicare covers it for diabetes only.

If a doctor prescribes Ozempic specifically for obesity or weight management, Medicare will not cover it under that use. This is true even though Ozempic does cause weight loss as a side effect.

The 2026 GLP-1 Bridge does not change this for Ozempic. The Bridge applies only to drugs with an explicit FDA approval for weight management: Wegovy, Zepbound, and Foundayo.

The Solution: Wegovy

Wegovy is the weight-management version of semaglutide. It contains the same active ingredient as Ozempic but at a higher weekly dose — 2.4 mg versus Ozempic's maximum of 2 mg. Novo Nordisk ran separate clinical trials at the higher dose and received FDA approval in 2021 specifically for chronic weight management in adults with obesity or weight-related conditions.

Because Wegovy has a weight-management indication, it qualifies for the Medicare GLP-1 Bridge. Eligible Medicare Part D members pay a flat $50 per month for Wegovy starting July 1, 2026 — compared to over $1,300 per month without coverage.

Ozempic vs. Wegovy on Medicare

	Ozempic	Wegovy
Active ingredient	Semaglutide	Semaglutide
Approved for	Type 2 diabetes	Chronic weight management
Medicare covers for	Diabetes (Part D)	Weight loss (Bridge)
Monthly cost on Medicare	Standard Part D copay	$50 flat
Prior authorization	Standard Part D PA	To CMS directly

What If My Doctor Prescribed Ozempic for Weight Loss?

Some doctors prescribe Ozempic off-label for weight management, especially if a patient cannot get Wegovy covered through private insurance. Medicare will not cover this. If your goal is weight-loss coverage, ask your doctor specifically to prescribe Wegovy — the version with the weight-management approval that triggers Bridge eligibility.

If your doctor is unfamiliar with the Bridge, share the Medicare GLP-1 Bridge guide on this site. The prior authorization for Wegovy goes directly to CMS, not to your Part D plan — which is different from how most prescriptions work.

What to Ask at Your Next Appointment

Bring these questions to your doctor:

"Does my BMI qualify me for the Medicare GLP-1 Bridge?"
"Can you prescribe Wegovy instead of Ozempic so I qualify for the $50 Bridge rate?"
"Are you familiar with submitting the prior authorization to CMS rather than to my Part D plan?"

The free 2-minute eligibility quiz will tell you whether you likely qualify before you walk into the office — so you can make the most of your appointment time.

Track Your Progress

Already on a GLP-1? Use the free CairnSpace tracker to log your daily protein, hydration, symptoms, and weight — built specifically for people on GLP-1 medications. No sign-up fees, no ads.